Hi all. Only recently bought into TILS. Doing my research i saw an article about Accustem applying for CE Mark Approval in November. Surely if that passes (usually 4-6 week process) it will have a big impact on Accustem's valuation. On approval then looking to Commercialize in Q2 2021 & finally FDA approval next year. Is this on track still ?
Hi whimax. New here and to investing in shares. If as you say, Accustem is sold before listing, what happens to our shares in Accustem in this scenario ? Would a value be attached to them ?